Why Biosimilar Drug Names Might Soon Contain Unhelpful Gibberish

Would you know the difference between replicamab, replicamab-cznm and replicamab-hjxf? The FDA has decided this is most helpful and useful for nonproprietary names of biosimilars.

from Forbes – Tech http://ift.tt/2mddhZ9
via IFTTT